WallStreetZenWallStreetZen

NASDAQ: NNNN
Anbio Biotechnology Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Anbio Biotechnology earnings were $6.4M for the trailing 12 months ending Dec 31, 2025, with 162.5% growth year over year. The latest NNNN earnings report on Dec 31, 2025 announced Q4 2025 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, NNNN reported annual earnings of $6.4M, with 169.9% growth.

NNNN past earnings growth

How has NNNN's earnings growth performed historically?

Company
162.5%
Industry
12.28%
Market
90.64%
NNNN's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
NNNN's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
NNNN's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

NNNN earnings history

Current Revenue
$8.6M
Current Earnings
$6.4M
Current Profit Margin
74.1%

NNNN Return on Equity

Current Company
27%
Current Industry
10.2%
Current Market
28.9%
NNNN's Return on Equity (27%)... subscribe to Premium to read more.
High Return on Equity Performance

NNNN Return on Assets

Current Company
26%
Current Industry
8.1%
NNNN is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when NNNN announces earnings.

NNNN Return on Capital Employed

Current Company
21.24%
Current Industry
9%
NNNN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

NNNN vs Medical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
NNNN$6.40M$6.40M-100.00%$0.15
NVST$364.50M$47.00M+5.92%$0.28
MMSI$348.67M$139.34M+92.03%$2.35
STVN$353.35M$164.52M+8.34%$0.60
TFX-$661.66M-$905.64MN/A-$20.30
View Top Medical Stocks

Anbio Biotechnology Earnings Reports & History FAQ

What were Anbio Biotechnology's earnings last quarter?

Anbio Biotechnology (NASDAQ: NNNN) reported Q4 2025 earnings per share (EPS) of N/A, up N/A year over year. Total NNNN earnings for the quarter were N/A. In the same quarter last year, Anbio Biotechnology's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Anbio Biotechnology stock.

Is Anbio Biotechnology profitable or losing money?

As of the last Anbio Biotechnology earnings report, Anbio Biotechnology is currently profitable. Anbio Biotechnology's net profit (also called net income) for the twelve months ending Dec 31, 2025 was $6.40 million, a 169.86% increase year over year.

What was NNNN's earnings growth in the past year?

As of Anbio Biotechnology's earnings date in Q2 2026, Anbio Biotechnology's earnings has grown 162.5% year over year. This is 150.22 percentage points higher than the US Medical Instruments & Supplies industry earnings growth rate of 12.28%. NNNN earnings in the past year totalled $6.40 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.